While many of the identified changes in gene expression, such as the overexpression of GPC6, are likely to be a compensatory response to the growth impairment, we hypothesised that there would be a smaller number of genes with altered expression which are key to the pathogenic process underlying 3-M syndrome. The gene discussed is GPC6; the disease is 3-M syndrome.